Osteoporotic fractures in older women
Abstract
A case review of postmenopausal osteoporosis is presented in the context of recent literature in the field. Given the case patient's high risk for future fracture, a thorough workup and pharmacologic intervention are reasonable. Etiology of the patient's disease is explored, particularly vitamin D insufficiency, low body weight, smoking history, celiac sprue, use of glucocorticoids, and estrogen status. Means of reducing fracture risk include lifestyle changes, calcium and vitamin D repletion, antiresorptive therapy, and patient education. Development of new therapies to further reduce fracture risk in such individuals, and efficient strategies to target interventions toward those at highest risk, are needed.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.